Apax Funds to acquire Rodenstock Group

Rodenstock (Apax-backed) Acquires Indo from Ergon Capital Partners

May 19, 2022

Medical Devices

Rodenstock Group, a portfolio company of Apax Partners, has agreed to acquire the majority stake in Indo from Ergon Capital Partners III SA; minority investors Sherpa Capital and Oquendo Capital are also selling their stakes while Indo's management will reinvest in the combined group. Indo, a leading Spanish manufacturer of ophthalmic lenses and distributor of optical equipment with ~440 employees and production plants in Barcelona and Tangier, will join Rodenstock subject to antitrust clearance.

Inspecs Group plc Acquires Eschenbach Holding GmbH from Equistone

November 19, 2020

Consumer Products

British eyewear designer and manufacturer Inspecs Group plc has agreed to acquire a majority stake in Nuremberg-based Eschenbach Holding GmbH from funds advised by Equistone Partners Europe. The deal (reported at approximately €94.85 million) combines two leading eyewear businesses to strengthen the enlarged group's global market position, broaden product and customer portfolios and accelerate international expansion; the transaction remains subject to regulatory approvals.

Apax Funds Makes Strategic Growth Investment in CohnReznick

February 26, 2025

Professional Services

Funds advised by Apax Partners LLP have made the first institutional, strategic growth investment in CohnReznick LLP. The capital will support CohnReznick’s growth plan—expanding service lines, advancing its technology platform, pursuing targeted acquisitions, and accelerating geographic and talent investments.

Oakley Capital Origin Fund I Acquires Majority Stake in Horizons Optical

March 18, 2024

Medical Devices

Oakley Capital Origin Fund I is acquiring a majority stake in Horizons Optical from Sherpa Capital, with CEO Santiago Soler retaining a significant share and remaining CEO. Horizons, founded in Barcelona in 2017, provides proprietary medical software and scanning equipment used by independent laboratories and opticians to manufacture premium bespoke spectacle lenses; Oakley will support international expansion and R&D, and invest in Sales & Marketing to accelerate growth.

Funds Advised by Permira Acquire Neuraxpharm from Funds Advised by Apax Partners

September 22, 2020

Pharmaceuticals

Funds advised by Permira have agreed to acquire the controlling stake in Neuraxpharm, a leading European specialty pharmaceuticals company focused on central nervous system (CNS) disorders, from funds advised by Apax Partners. Financial terms were not disclosed; Neuraxpharm had annual revenues in excess of €460 million and around 850 employees under Apax's ownership.

EssilorLuxottica Acquires Optegra from MidEuropa

May 30, 2025

Healthcare Services

EssilorLuxottica has agreed to acquire Optegra, a leading European ophthalmology platform, from private equity firm MidEuropa. The transaction — subject to customary antitrust clearance and expected to close later this year — gives EssilorLuxottica a network of 70+ eye hospitals and diagnostic facilities across Europe and expands its clinical ophthalmology capabilities and European footprint.